Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -8.304% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) COc1ccccc1OCC(=O)NN=C(Cc1ccccc1)Cc1ccccc1
b.) O=C(CSc1nnc(-c2cccnc2)n1C1CCCCC1)NC1CCCC1
Answer: b. O=C(CSc1nnc(-c2cccnc2)n1C1CCCCC1)NC1CCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CSc1nnc(-c2cccnc2)n1C1CCCCC1)NC1CCCC1
O=C(CSc1nnc(-c2cccnc2)n1C1CCCCC1)NC1CCCC1
2-[(4-cyclohexyl-5-pyridin-3-yl-1,2,4-triazol-3-yl)sulfanyl]-N-cyclopentylacetamide